194 related articles for article (PubMed ID: 28806881)
1. Cancer Risk Stratification of Indeterminate Thyroid Nodules: A Cytological Approach.
Valderrabano P; Khazai L; Thompson ZJ; Leon ME; Otto KJ; Hallanger-Johnson JE; Wadsworth JT; Wenig BM; Chung CH; Centeno BA; McIver B
Thyroid; 2017 Oct; 27(10):1277-1284. PubMed ID: 28806881
[TBL] [Abstract][Full Text] [Related]
2. Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis.
Valderrabano P; Khazai L; Thompson ZJ; Sharpe SC; Tarasova VD; Otto KJ; Hallanger-Johnson JE; Wadsworth JT; Wenig BM; Chung CH; Centeno BA; McIver B
Thyroid; 2018 Feb; 28(2):210-219. PubMed ID: 29160163
[TBL] [Abstract][Full Text] [Related]
3. Combining the American Thyroid Association's Ultrasound Classification with Cytological Subcategorization Improves the Assessment of Malignancy Risk in Indeterminate Thyroid Nodules.
Larcher de Almeida AM; Delfim RLC; Vidal APA; Chaves MCDCM; Santiago ACL; Gianotti MF; Gonçalves MDDC; Vaisman M; de Carvalho DP; Teixeira PFDS
Thyroid; 2021 Jun; 31(6):922-932. PubMed ID: 33143569
[No Abstract] [Full Text] [Related]
4. Thyroid Nodules with Indeterminate Cytology: Utility of the American Thyroid Association Sonographic Patterns for Cancer Risk Stratification.
Valderrabano P; McGettigan MJ; Lam CA; Khazai L; Thompson ZJ; Chung CH; Centeno BA; McIver B
Thyroid; 2018 Aug; 28(8):1004-1012. PubMed ID: 29848195
[TBL] [Abstract][Full Text] [Related]
5. Importance of cytological subclassification of thyroid nodules with Bethesda category III cytology (AUS/FLUS) into architectural atypia only and nuclear atypia: A prospective study.
Rosario PW; Calsolari MR
Diagn Cytopathol; 2017 Jul; 45(7):604-607. PubMed ID: 28425211
[TBL] [Abstract][Full Text] [Related]
6. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
7. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
Lim JXY; Nga ME; Chan DKH; Tan WB; Parameswaran R; Ngiam KY
Thyroid; 2018 Apr; 28(4):511-521. PubMed ID: 29596039
[TBL] [Abstract][Full Text] [Related]
8. Indeterminate thyroid nodules (TIR3A/TIR3B) according to the new Italian reporting system for thyroid cytology: A cytomorphological study.
Rullo E; Minelli G; Bosco D; Nardi F; Grani G; Durante C; Ascoli V
Cytopathology; 2019 Sep; 30(5):475-484. PubMed ID: 31112332
[TBL] [Abstract][Full Text] [Related]
9. Subtype of atypia on cytology and risk of malignancy in pediatric thyroid nodules.
Cherella CE; Hollowell ML; Smith JR; Zendejas B; Modi BP; Cibas ES; Wassner AJ
Cancer Cytopathol; 2022 May; 130(5):330-335. PubMed ID: 35119774
[TBL] [Abstract][Full Text] [Related]
10. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
Kelman AS; Rathan A; Leibowitz J; Burstein DE; Haber RS
Thyroid; 2001 Mar; 11(3):271-7. PubMed ID: 11327619
[TBL] [Abstract][Full Text] [Related]
11. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
[TBL] [Abstract][Full Text] [Related]
12. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
[TBL] [Abstract][Full Text] [Related]
13. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
[TBL] [Abstract][Full Text] [Related]
14. Differences in Thyroid Nodule Cytology and Malignancy Risk Between Children and Adults.
Cherella CE; Angell TE; Richman DM; Frates MC; Benson CB; Moore FD; Barletta JA; Hollowell M; Smith JR; Alexander EK; Cibas ES; Wassner AJ
Thyroid; 2019 Aug; 29(8):1097-1104. PubMed ID: 31298618
[No Abstract] [Full Text] [Related]
15. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and Management of Indeterminate Thyroid Nodules: The Revolution of Risk Stratification Beyond Cytological Diagnosis.
Valderrabano P; McIver B
Cancer Control; 2017; 24(5):1073274817729231. PubMed ID: 28975825
[TBL] [Abstract][Full Text] [Related]
17. Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses.
Rossi M; Lupo S; Rossi R; Franceschetti P; Trasforini G; Bruni S; Tagliati F; Buratto M; Lanza G; Damiani L; Degli Uberti E; Zatelli MC
Endocrine; 2017 Jul; 57(1):98-107. PubMed ID: 27623969
[TBL] [Abstract][Full Text] [Related]
18. Tumor Growth Rate Does Not Predict Malignancy in Surgically Resected Thyroid Nodules Classified as Bethesda Category III with Architectural Atypia.
Kim M; Jeon MJ; Han M; Lee JH; Song DE; Baek JH; Kim TY; Kim WB; Shong YK; Kim WG
Thyroid; 2019 Feb; 29(2):216-221. PubMed ID: 30421654
[TBL] [Abstract][Full Text] [Related]
19. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
[TBL] [Abstract][Full Text] [Related]
20. Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
Baca SC; Wong KS; Strickland KC; Heller HT; Kim MI; Barletta JA; Cibas ES; Krane JF; Marqusee E; Angell TE
Cancer Cytopathol; 2017 May; 125(5):313-322. PubMed ID: 28152275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]